Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Targeting A Key Actor In The Spread Of Triple Negative Breast Cancer

This article was originally published in Start Up

Executive Summary

Researchers have identified a molecule found in primary tumors whose suppression leads to metastasis of cancer cells to the lung and lymph nodes. Their findings, which dovetail nicely with clinical research efforts at several companies, could quickly lead to testing of drugs to treat triple negative breast cancer, which has the worst outcome among breast cancer patients due to the high incidence of recurrence and metastatic spread.

Related Content

Topics

Related Companies

Related Deals

UsernamePublicRestriction

Register

SC092387

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel